Mesoblast MEOBF
NASDAQ MEOBF
$1.90 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Mesoblast (MEOBF) Long-Term Deferred Tax (2017 - 2021)

Mesoblast's (MEOBF) quarterly Long-Term Deferred Tax came in at $80.2 million in Q4 2021, little changed year-over-year from $80.1 million in Q4 2020, and little changed quarter-over-quarter from $80.2 million in Q3 2021.

Analysis

Mesoblast (MEOBF) Long-Term Deferred Tax (2017 - 2021) Analysis & Trends

Mesoblast has disclosed Long-Term Deferred Tax across 5 years of filings, most recently posting $80.2 million for Q4 2021.

  • In Q4 2021, Long-Term Deferred Tax changed 0.11% year-over-year to $80.2 million; the TTM figure through Dec 2021 stood at $80.2 million (changed 0.11% YoY), while the FY2021 annual figure was $80.2 million, up 1.35% from the prior year.
  • Long-Term Deferred Tax came in at $80.2 million for Q4 2021 at Mesoblast, roughly flat from $80.2 million in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $80.2 million in Q3 2021 to a low of $56.6 million in Q2 2018.
  • Average Long-Term Deferred Tax over 5 years is $73.2 million, with a median of $78.2 million recorded in 2017.
  • Year-over-year, Long-Term Deferred Tax declined 27.68% in 2018 and rose 21.22% in 2019.
  • Over 5 years, Long-Term Deferred Tax stood at $78.2 million in 2017, then slipped by 23.17% to $60.1 million in 2018, then rose by 21.22% to $72.9 million in 2019, then grew by 9.97% to $80.1 million in 2020, then advanced by 0.11% to $80.2 million in 2021.
  • Per Business Quant data, the three most recent Long-Term Deferred Tax figures were $80.2 million in Q4 2021, $80.2 million in Q3 2021, and $80.2 million in Q2 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Krystal Biotech 10.27 Bn 9.43 Bn 112.79 Mn
2 CRISPR Therapeutics AG 5.17 Bn 5.17 Bn -
3 Iovance Biotherapeutics 3.79 Bn 3.49 Bn 55.72 Mn
4 Legend Biotech 3.68 Bn 2.71 Bn 251.50 Mn
5 uniQure 3.05 Bn 3.05 Bn 5.49 Mn
6 Beam Therapeutics 2.65 Bn 2.65 Bn -
7 Precigen 2.44 Bn 2.44 Bn 52.17 Mn
8 Sarepta Therapeutics 2.33 Bn 1.53 Bn 251.87 Mn
9 Vericel 1.99 Bn 1.83 Bn 56.40 Mn
10 Mesoblast 246.02 Mn 143.11 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 80.21 Mn
Sep 30, 2021 80.25 Mn
Jun 30, 2021 80.16 Mn
Mar 31, 2021 80.20 Mn
Dec 31, 2020 80.12 Mn
Sep 30, 2020 79.91 Mn
Jun 30, 2020 79.10 Mn
Mar 31, 2020 74.78 Mn
Dec 31, 2019 72.85 Mn
Sep 30, 2019 67.45 Mn
Jun 30, 2019 65.43 Mn
Mar 31, 2019 62.28 Mn
Dec 31, 2018 60.10 Mn
Jun 30, 2018 56.57 Mn
Jun 30, 2017 78.23 Mn